SCHEMBL7089306

SCHEMBL7089306

CCc1cc(C)cc(=O)n1O

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 19/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11822962 0.82 IDH1 (0.62) IDH1
SCHEMBL7091685 0.82 IDH1 (0.62) IDH1
SCHEMBL7087597 0.80 IDH1 (0.61) IDH1
SCHEMBL7094059 0.79 IDH1 (0.59) IDH1
SCHEMBL11856342 0.78 IDH1 (0.54) IDH1
SCHEMBL10934346 0.78 IDH1 (0.54) IDH1
SCHEMBL10726805 0.78 IDH1 (0.54) IDH1
SCHEMBL7087767 0.78 IDH1 (0.54) IDH1
SCHEMBL7087631 0.78 IDH1 (0.54) IDH1
SCHEMBL4720732 0.77 IDH1 (0.57) IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4626862-A1 PROCESS FOR THE PREPARATION OF N-HYDROXYPYRIDONE COMPOUNDS CLARIANT INTERNATIONAL LTD (CH) 2025-10-08 EP claimed
WO-2024115319-A1 PROCESS FOR THE PREPARATION OF N-HYDROXYPYRIDONE COMPOUNDS CLARIANT INTERNATIONAL LTD (CH) 2024-06-06 WO claimed
US-20030228340-A1 Methods for treating rosacea with pyridones MEDICIS PHARMACEUTICAL CORPORATION 2003-12-11 US disclosed
WO-2003084538-A1 METHODS FOR TREATING ROSACEA WITH PYRIDONES MEDICIS PHARMACEUTICAL CORPORATION (US) 2003-10-16 WO disclosed
US-3972888-A Process for the preparation of 1-hydroxy-pyridones HOECHST AKTIENGESELLSCHAFT (DT) 1976-08-03 US disclosed
US-3968118-A Process for the manufacture of 1-hydroxy-2-pyridones HOECHST AKTIENGESELLSCHAFT (DT) 1976-07-06 US disclosed